3D Bioprinting of In Vitro Models Using Hydrogel-Based Bioinks

Area of Science:

• Biotechnology
• Regenerative Medicine
• Pathology

Background:

• The COVID-19 pandemic highlighted the urgent need for rapid development of therapeutic agents.
• Traditional in vitro models face limitations in accurately mimicking human physiology and disease progression.
• Social distancing measures during the pandemic underscored the importance of remote research tools.

Purpose of the Study:

• To provide an in-depth assessment of 3D bioprinting technology and bioinks for in vitro modeling.
• To discuss recent advancements and future prospects of 3D bioprinting in disease research.
• To evaluate the potential of 3D bioprinting in establishing reliable models for emerging infectious diseases.

Main Methods:

• Review and analysis of recent literature on 3D bioprinting techniques and bioink development.
• Assessment of high-precision 3D bioprinting for creating organoid and tissue models.
• Evaluation of the application of 3D bioprinting in validating pathological behaviors and therapeutic agents.

Main Results:

• 3D bioprinting enables the creation of sophisticated in vitro models that replicate human organ and tissue functions.
• Advancements in bioinks and printing resolution enhance the fidelity of these models.
• These models show promise in accelerating the identification and validation of therapeutic agents for diseases like COVID-19.

Conclusions:

• 3D bioprinting is a transformative technology for developing advanced in vitro models for rapid response to emerging diseases.
• The technology facilitates the study of pathogen behavior and the testing of potential therapeutics.
• Continued innovation in 3D bioprinting and bioinks will be crucial for future infectious disease research and drug discovery.